WHO panel: Use of unproven Ebola treatments ethical
This article was originally published in Scrip
Executive Summary
A special panel of medical ethicists and other experts convened by the World Health Organization (WHO) said it is ethical to offer unproven experimental interventions with unknown efficacy and adverse effects as potential treatments for or preventions against Ebola – a disease which has now killed more than 1,000 people in Guinea, Liberia, Nigeria, and Sierra Leone, with the international agency reporting 1,848 cases in the largest, most severe outbreak in history.